Ubs Group Ag Curis Inc Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$0.57 - $0.99 $1,799 - $3,125
-3,157 Reduced 78.94%
842 $0
Q1 2023

May 12, 2023
BUY
$0.51 - $0.78 $828 - $1,266
1,624 Added 68.38%
3,999 $2,000
Q4 2022

Feb 08, 2023
SELL
$0.47 - $17.22 $23,009 - $843,039
-48,957 Reduced 95.37%
2,375 $1,000
Q3 2022

Nov 10, 2022
BUY
$0.74 - $15.01 $24,590 - $498,797
33,231 Added 183.59%
51,332 $36,000
Q2 2022

Aug 10, 2022
BUY
$0.71 - $2.43 $11,312 - $38,717
15,933 Added 734.92%
18,101 $18,000
Q1 2022

May 16, 2022
SELL
$2.31 - $5.13 $1.13 Million - $2.51 Million
-490,157 Reduced 99.56%
2,168 $6,000
Q4 2021

Feb 14, 2022
BUY
$4.45 - $8.09 $606,503 - $1.1 Million
136,293 Added 38.28%
492,325 $2.34 Million
Q3 2021

Nov 15, 2021
BUY
$6.94 - $8.85 $2.45 Million - $3.13 Million
353,651 Added 14853.04%
356,032 $2.79 Million
Q2 2021

Aug 13, 2021
SELL
$7.45 - $16.27 $952,549 - $2.08 Million
-127,859 Reduced 98.17%
2,381 $19,000
Q1 2021

May 12, 2021
BUY
$8.78 - $12.8 $1.13 Million - $1.64 Million
128,319 Added 6679.8%
130,240 $1.48 Million
Q4 2020

Feb 11, 2021
BUY
$1.08 - $8.2 $510 - $3,878
473 Added 32.67%
1,921 $16,000
Q3 2020

Nov 12, 2020
SELL
$0.95 - $1.42 $5,256 - $7,856
-5,533 Reduced 79.26%
1,448 $2,000
Q2 2020

Jul 31, 2020
SELL
$0.63 - $1.7 $468 - $1,264
-744 Reduced 9.63%
6,981 $9,000
Q1 2020

May 01, 2020
BUY
$0.67 - $1.85 $2,220 - $6,130
3,314 Added 75.13%
7,725 $5,000
Q4 2019

Feb 14, 2020
SELL
$1.36 - $2.44 $4,328 - $7,766
-3,183 Reduced 41.91%
4,411 $7,000
Q3 2019

Nov 14, 2019
BUY
$1.74 - $2.83 $6,792 - $11,048
3,904 Added 105.8%
7,594 $17,000
Q2 2019

Aug 14, 2019
SELL
$1.36 - $2.35 $6,129 - $10,591
-4,507 Reduced 54.98%
3,690 $7,000
Q1 2019

May 14, 2019
BUY
$0.78 - $2.01 $2,635 - $6,791
3,379 Added 70.13%
8,197 $16,000
Q4 2018

Feb 14, 2019
BUY
$0.62 - $2.25 $1,401 - $5,087
2,261 Added 88.42%
4,818 $3,000
Q3 2018

Nov 14, 2018
SELL
$1.38 - $1.94 $3,761 - $5,288
-2,726 Reduced 51.6%
2,557 $5,000
Q2 2018

Aug 14, 2018
BUY
$1.73 - $3.35 $9,139 - $17,698
5,283 New
5,283 $9,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email